What is it about?
Post-transplant bendamustine may prove to be a better approach that post-transplant cyclophosphamide in haploidentical BMT
Featured Image
Why is it important?
This adds to the field of Haplo-transplantation as an additional approach which warrants clinical investigation
Perspectives
Based on our murine findings a clinical trial is underway evaluating the role of post-transplant bendamustine in patients with leukemia and lymphoma
Emmanuel Katsanis
University of Arizona
Read the Original
This page is a summary of: Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation, British Journal of Haematology, March 2016, Wiley,
DOI: 10.1111/bjh.14034.
You can read the full text:
Contributors
The following have contributed to this page
